Look for:

Our offer for

BIOGEN IDEC INC.


ISIN:
US09062X1037
WKN:
09062X103

2022/10/03 16:38:19
Price
260.7049 USD
Difference -2.36% (-6.30)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)39,570 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)260.68 USD (100)
Ask (Ask size)260.94 USD (100)
Open269.00 USD
High269.50 USD
Low260.7049 USD
Close (prev. day)267.00 USD
VWAP264.75371 USD
Volume (pcs)746,710
Trading volume197,831,974.00
Number of trades16,096
Last size200

Futures and Options

Related Futures-
Related Options-

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/10/03 16:38:19
Price
260.7049 USD
Difference -2.36% (-6.30)

General attributes

ISINUS09062X1037
SymbolBIIB
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)39,570 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)260.68 USD (100)
Ask (Ask size)260.94 USD (100)
Open269.00 USD
High269.50 USD
Low260.7049 USD
Close (prev. day)267.00 USD
VWAP264.75371 USD
Volume (pcs)746,710
Trading volume197,831,974.00
Number of trades16,096
Last size200

Performance and Risk

6m1Y3Y
Perf (%)+26.52%-5.65%+14.68%
Perf (abs.)+55.97-15.99+34.18
Beta1.070.910.84
Volatility58.4447.4351.72
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)240.2860 USD (5,607,255)
Ø price 30 days | Ø volume 30 days (pcs.)209.2627 USD (1,690,581)
Ø price 100 days | Ø volume 100 days (pcs.)208.1937 USD (1,215,327)
Ø price 250 days | Ø volume 250 days (pcs.)222.5717 USD (1,278,692)
YTD High | date283.4400 USD (2022/09/28)
YTD Low | date187.1600 USD (2022/05/09)
52 Weeks High | date290.7600 USD (2021/10/07)
52 Weeks Low | date187.1600 USD (2022/05/09)

All listings for BIOGEN IDEC INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/10/0316:37266.00 EUR0.0924
Vienna Stock Exchange2022/10/0313:02274.70 EUR0.012
Tradegate2022/10/0316:26269.45 EUR0.1835
Stuttgart2022/10/0314:53275.30 EUR0.003
SIX Swiss Exchange2022/09/2817:36222.00 CHF0.001
Nasdaq2022/10/0316:38260.7049 USD197.8316,097
Munich2022/10/0308:10272.60 EUR0.001
London Stock Exchange2022/09/2715:37199.99 USD0.011
Hanover2022/10/0308:19270.40 EUR0.001
Hamburg2022/10/0308:19270.40 EUR0.001
Frankfurt2022/10/0311:34272.00 EUR0.002
Duesseldorf2022/10/0316:01271.40 EUR0.009
Berlin2022/10/0316:32266.95 EUR0.0010

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=2033&ID_TYPE_IMAGE_LOGO=2

Contact Details

BIOGEN INC.
- -
225 Binney Street - 02142 Cambridge
Telefon: 1-617-679-2000
Fax: -
E-mail: info@biogen.com

PDF Downloads

Company report: BIOGEN IDEC INC.PDF Download

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for the treatment of multiple sclerosis, SPINRAZA for the treatment of spinal muscular atrophy, and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.

Members of Management Board

Stelios PapadopoulosChairman of Board of Directors
Alexander DennerMember of Board of Directors
Eric RowinskyMember of Board of Directors
Maria FreireMember of Board of Directors
Richard MulliganMember of Board of Directors
Stephen SherwinMember of Board of Directors
Caroline DorsaMember of Board of Directors
Jesus MantasMember of Board of Directors
William HawkinsMember of Board of Directors
William JonesMember of Board of Directors
Michel VounatsosChairman of Managing Board
Ginger GregoryMember of Executive Committee
Alphonse GaldesMember of Executive Committee
Michael McDonnellMember of Executive Committee
Rachid IzzarMember of Executive Committee
Susan H. AlexanderMember of Executive Committee






Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer